GET THE APP

Journal of Multiple Sclerosis

ISSN - 2376-0389
NLM - 101654564

Citations Report

Journal of Multiple Sclerosis : Citations & Metrics Report

Articles published in Journal of Multiple Sclerosis have been cited by esteemed scholars and scientists all around the world. Journal of Multiple Sclerosis has got h-index 11, which means every article in Journal of Multiple Sclerosis has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Multiple Sclerosis.

	2022	2021	2020	2019	2018
Year wise published articles	55	59	6	3	9
Year wise citations received	54	59	46	57	43

Journal total citations count	521
Journal Impact Factor	2.30
Journal 5 years Impact Factor	2.28
Journal CiteScore	1.96
Journal h-index	11

Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal CiteScore
CiteScore_y = Citations_y + Citations_y-1 + Citations_y-2 + Citations _y-3 / Published articles_y + Published articles_y-1 + Published articles_y-2 + Published articles _y-3

Important Citations

McLaughlin PJ, Zagon IS (2015) Duration of opioid receptor blockade determines biotherapeutic response. Biochemical pharmacology 97: 236-46. View at Publisher View at Google Scholar
Charvet LE, Taub E, Cersosimo B, Rosicki C, Melville P (2015) The Montreal Cognitive Assessment (MoCA) in Multiple Sclerosis: Relation to Clinical Features. J Mult Scler 2: 2376-0389. View at Publisher View at Google Scholar
Contini C, Granieri E, Fainardi E, Stratton CW (2015) Role of Chlamydophila pneumoniae in the Pathogenesis of Chronic Cerebrospinal Venous Insuffiency in Patients with Multiple Sclerosis. J Mult Scler (Foster City) 2: 2376-0389. View at Publisher View at Google Scholar
ŠalinoviÄ‡ H (2016) Lijekovi koji modificiraju tijek bolesti-multipla skleroza (Doctoral dissertation, University of Zagreb. Faculty of Pharmacy and Biochemistry. Department of pharmacology. View at Publisher View at Google Scholar
Å alinoviÄ‡ H (2016) DIPLOMSKI RAD. View at Publisher View at Google Scholar
Modi KK, Rangasamy SB, Dasarathi S, Roy A, Pahan K (2016) Cinnamon Converts Poor Learning Mice to Good Learners: Implications for Memory Improvement. Journal of Neuroimmune Pharmacology 11: 693-707. View at Publisher View at Google Scholar
Chen YF, Wang YW, Huang WS, Lee MM, Wood WG (2016) Trans-cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of iNOS, COX-2 expression and NFκ-B signaling pathway. Neuromolecular medicine 18: 322-233. View at Publisher View at Google Scholar
Ben-Zacharia AB (2015) Screening for Depression in Adult Patients with Multiple Sclerosis. J Mult Scler 2: 2376-0389. View at Publisher View at Google Scholar
Freiesleben S, Hecker M, Zettl UK, Fuellen G, Taher L (2016) Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms. Scientific Reports 6. View at Publisher View at Google Scholar
Galea I, Elwood E, Lim ZW, Naveed H (2016) Lymphopenia in treatment-naive relapsing multiple sclerosis. Neurology: Neuroimmunology & Neuroinflammation 11: 1-9. View at Publisher View at Google Scholar
Lim ZW, Elwood E, Naveed H, Galea I (2016) Lymphopenia in treatment-naive relapsing multiple sclerosis. Neurology-Neuroimmunology Neuroinflammation 3: e275. View at Publisher View at Google Scholar
Karim RM, Wang YF (2016) The Study Progress of B Cells and Neuroimmunological Diseases. J Neurol Neurophysiol 7: 369. View at Publisher View at Google Scholar
Giacomini E, Rizzo F, Etna MP, Cruciani M, Mechelli R (2017) Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing–remitting multiple sclerosis patients. Multiple Sclerosis Journal 1: 1352458517695892. View at Publisher View at Google Scholar
Deng J, Pennati A, Cohen JB, Wu Y, Ng S, Wu JH, Flowers CR, Galipeau J (2016) GIFT4 fusokine converts leukemic B cells into immune helper cells. Journal of translational medicine 14: 106. View at Publisher View at Google Scholar
Alexopoulos H, Biba A, Dalakas MC (2016) Anti-B-cell therapies in autoimmune neurological diseases: Rationale and efficacy trials. Neurotherapeutics 1: 20-33. View at Publisher View at Google Scholar
Claes N, Fraussen J, Stinissen P, Hupperts R, Somers V (2015) B cells are multifunctional players in multiple sclerosis pathogenesis: insights from therapeutic interventions. Frontiers in immunology 6. View at Publisher View at Google Scholar
Sánchez Morales C (2017) Alteraciones motoras, cognitivas y emocionales en la encefalomielitis autoinmune experimental. View at Publisher View at Google Scholar
Ludwig M, Turel AP, Zagon IS, McLaughlin PJ (2015) Take a look at the Recent articles. View at Publisher View at Google Scholar
Ludwig MD, Turel AP, Zagon IS, McLaughlin PJ (2016) Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis. Multiple Sclerosis Journal–Experimental, Translational and Clinical 2: 2055217316672242. View at Publisher View at Google Scholar
Ludwig MD, Turel AP, Zagon IS, McLaughlin PJ (2015) Treatment of clinically isolated syndrome and low dose naltrexone. Clin Case Reports Rev 1: 182-184. View at Publisher View at Google Scholar
Prev 1 2 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 Next »

+44-73-6204-9920

Top